Literature DB >> 26218738

Identifying clinically meaningful benchmarks for gait improvement after total hip arthroplasty.

Kharma C Foucher1.   

Abstract

There are no established benchmarks for gait mechanics after total hip arthroplasty (THA). This study sought to identify minimum clinically important postoperative (MCIP) or minimum clinically important improvement (MCII) values for self-selected walking speed, sagittal plane dynamic hip range of motion (HROM) (peak flexion-peak extension) and peak hip adduction moments measured during quantitative gait analysis. Preoperative and 1-year postoperative data collected during quantitative gait analysis, along with Harris Hip Scores (HHS), for 145 subjects were collected from a motion analysis data repository. The MCIP (or MCII) was defined as the 75th percentile mark on a plot of the cumulative percent of subjects with HHS ≥ 80 versus the postoperative value (or change) in the respective variable. 95% confidence intervals (CI) were calculated. Logistic regression was used to test the association of age, sex, BMI, and preoperative HHS with benchmarks. The MCIP of speed was 1.34 m/s (95%CI 1.30, 1.37); MCII was 0.32 (0.30, 0.35) m/s. The HROM MCIP was 30.0° (29.4°, 30.7°); MCII was 13.3° (12.1°, 14.8°). The adduction moment MCIP was 4.2% Body Weight × Height (4.0, 4.4); MCII was 0.87 (0.57, 1.17) % Body Weight × Height. Women were more likely to achieve MCII for HROM and MCIP for adduction moment (ORs 2.4-11.6, p ≤ 0.031). Lower BMI predicted HROM and adduction moment MCIPs (ORs 0.85-0.88, p ≤ 0.015). Lower preoperative HHS predicted speed, HROM and adduction moment MCIIs (ORs 0.95-0.97, p ≤ 0.012). With further validation, clinically-relevant gait benchmarks can enhance efforts to improve THA outcomes.
© 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  benchmarks; gait; outcomes assessment; rehabilitation; total hip arthroplasty

Mesh:

Year:  2015        PMID: 26218738     DOI: 10.1002/jor.22996

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  6 in total

1.  Gluteus Maximus Transfer following Total Hip Arthroplasty Does Not Improve Abductor Moment: A Case-Control Gait Analysis Study of 15 Patients with Gluteus Medius Disruption.

Authors:  Roland Zügner; Natalie Hjelmberg; Ola Rolfson; Christer Strömberg; Tuuli Saari
Journal:  J Clin Med       Date:  2022-06-02       Impact factor: 4.964

2.  Hip abductor strength and fatigue are associated with activity levels more than 1 year after total hip replacement.

Authors:  Kharma C Foucher; Christopher C Cinnamon; Colleen A Ryan; Samuel J Chmell; Kris Dapiton
Journal:  J Orthop Res       Date:  2017-11-28       Impact factor: 3.494

3.  Claudicating patients with peripheral artery disease have meaningful improvement in walking speed after supervised exercise therapy.

Authors:  Hafizur Rahman; Iraklis I Pipinos; Jason M Johanning; George Casale; Mark A Williams; Jonathan R Thompson; Yohanis O'Neill-Castro; Sara A Myers
Journal:  J Vasc Surg       Date:  2021-05-31       Impact factor: 4.268

4.  Different reliability of instrumented gait analysis between patients with unilateral hip osteoarthritis, unilateral hip prosthesis and healthy controls.

Authors:  Roland Zügner; Roy Tranberg; Vera Lisovskaja; Johan Kärrholm
Journal:  BMC Musculoskelet Disord       Date:  2018-07-18       Impact factor: 2.362

5.  Validation of inertial measurement units with optical tracking system in patients operated with Total hip arthroplasty.

Authors:  Roland Zügner; Roy Tranberg; John Timperley; Diana Hodgins; Maziar Mohaddes; Johan Kärrholm
Journal:  BMC Musculoskelet Disord       Date:  2019-02-06       Impact factor: 2.362

6.  Effect of Denosumab on Femoral Periprosthetic BMD and Early Femoral Stem Subsidence in Postmenopausal Women Undergoing Cementless Total Hip Arthroplasty.

Authors:  Hannu T Aro; Sanaz Nazari-Farsani; Mia Vuopio; Eliisa Löyttyniemi; Kimmo Mattila
Journal:  JBMR Plus       Date:  2019-08-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.